Stay updated on Nivolumab Plus Cabozantinib in Non-Clear Cell RCC Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Plus Cabozantinib in Non-Clear Cell RCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Plus Cabozantinib in Non-Clear Cell RCC Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    A sitewide NIH notice about a website transition and terminology appears above the unchanged 403 Forbidden page. The site revision label changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T21:58:09.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The footer revision number changed from v3.7.0 to v3.7.1 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-06T21:57:58.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error page instead of rendering the study record, indicating restricted access to the resource. The layout retains the site’s header and footer, reflecting a standard error page presentation.
    Difference
    0.5%
    Check dated 2026-09-29T22:13:54.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The page now displays a 403 error, replacing the study content with a minimal error screen and a Home link. This indicates access to the study record is blocked rather than providing study details.
    Difference
    20%
    Check dated 2026-09-22T22:28:41.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    Revision tag updated to v3.7.0 with v3.6.6 removed, indicating a backend page update rather than changes to study details.
    Difference
    0.1%
    Check dated 2026-09-15T20:53:22.000Z thumbnail image
  7. Check
    50 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.6, replacing the previous Revision: v3.6.5, indicating a small behind-the-scenes update.
    Difference
    0.1%
    Check dated 2026-09-01T19:51:12.000Z thumbnail image

Stay in the know with updates to Nivolumab Plus Cabozantinib in Non-Clear Cell RCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus Cabozantinib in Non-Clear Cell RCC Clinical Trial page.